China Medical System proposes secondary listing in Singapore
24/06/2025 16:59
June 24 (Reuters) - Hong Kong-listed China Medical System 0867.HK said on Tuesday it has applied for a secondary listing of its shares on the Singapore Exchange. The pharmaceutical company said it will not issue new shares on the Singapore exchange, and its primary listing would remain in Hong Kong. The news comes as Chinese firms look to expand in Southeast Asia amid global trade tensions, providing a boost to Singapore Exchange SGXL.SI. At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, Reuters reported in May, citing four sources. Despite being a popular venue for yield plays such as real estate investment trusts, the Singapore Exchange has been struggling to attract mega listings and bolster trading volumes. (Reporting by Rishav Chatterjee in Bengaluru; Editing by Leroy Leo) ((Rishav.Chatterjee@thomsonreuters.com;))
Recent news on Singapore Exchange
See all newsSGX mulls new coking coal and steel contracts, executive says
Singapore to establish OTC gold clearing system, introduce central bank gold-vaulting services
Baltic Exchange says Mercuria's lawsuit over Hormuz freight losses harming market
Brief: Singapore Exchange Posts Securities Market Turnover Value In April
Brief: Singapore Exchange Strengthens Technology And Operations Strategy To Support The Next Phase Of Its Infrastructure Growth